Therapeutics: Glucokinase (GCK; GK); glucokinase regulator (GCKR; GKRP)

Endocrine/metabolic disease

INDICATION: Diabetes

In vitro and rat studies suggest a thiazole sulfone-based disruptor of the GCK-GCKR complex could help treat Type II

Read the full 212 word article

User Sign In